关于乳房切除术在转移性乳腺癌中作用的实用共识建议。
Practical consensus recommendations regarding role of mastectomy in metastatic breast cancer.
作者信息
Somsekhar S P, Geeta K, Jain R, Nayyer R, Halder S, Malik V K, Parikh Purvish, Aggarwal S, Koul R
机构信息
Department of Surgical Oncology, Manipal Hospital, Bengaluru, Karnataka, India.
Department of Surgical Oncology, Max Hospital, New Delhi, India.
出版信息
South Asian J Cancer. 2018 Apr-Jun;7(2):79-82. doi: 10.4103/sajc.sajc_106_18.
Abstract
Whether to recommend mastectomy in metastatic disease or not has been a matter of debate. Is local therapy, such as mastectomy, of any benefit in advanced breast cancer is the main question. This expert group used data from published literature, practical experience and opinion of a large group of academic oncologists to arrive at these practical consensus recommendations for the benefit of community oncologists.
摘要
对于转移性疾病是否推荐乳房切除术一直存在争议。局部治疗，如乳房切除术，在晚期乳腺癌中是否有益是主要问题。该专家小组利用已发表文献的数据、实践经验以及一大批学术肿瘤学家的意见，得出了这些实用的共识性建议，以造福社区肿瘤学家。
相似文献
1
Practical consensus recommendations regarding role of mastectomy in metastatic breast cancer.
South Asian J Cancer. 2018 Apr-Jun;7(2):79-82. doi: 10.4103/sajc.sajc_106_18.
2
Practical consensus recommendations regarding role of postmastectomy radiation therapy.
South Asian J Cancer. 2018 Apr-Jun;7(2):87-90. doi: 10.4103/sajc.sajc_108_18.
3
Practical consensus recommendations regarding the management of HER2 neu positive metastatic breast cancer.
South Asian J Cancer. 2018 Apr-Jun;7(2):146-150. doi: 10.4103/sajc.sajc_123_18.
4
Practical consensus recommendations regarding the use of hormonal therapy in metastatic breast cancer.
South Asian J Cancer. 2018 Apr-Jun;7(2):137-141. doi: 10.4103/sajc.sajc_121_18.
5
ICON 2013: practical consensus recommendations for hormone receptor-positive Her2-negative advanced or metastatic breastcancer.
Indian J Cancer. 2014 Jan-Mar;51(1):73-9. doi: 10.4103/0019-509X.134650.
6
Practical consensus recommendations on Her2 +ve breast cancer with solitary brain mets.
South Asian J Cancer. 2018 Apr-Jun;7(2):118-122. doi: 10.4103/sajc.sajc_116_18.
7
Practical consensus recommendations on duration of adjuvant hormonal therapy in breast cancer.
South Asian J Cancer. 2018 Apr-Jun;7(2):142-145. doi: 10.4103/sajc.sajc_122_18.
8
Practical consensus recommendations on ovarian suppression in early breast cancer (adjuvant).
South Asian J Cancer. 2018 Apr-Jun;7(2):151-155. doi: 10.4103/sajc.sajc_125_18.
9
Practical consensus recommendations regarding the management of hormone receptor positive early breast cancer in elderly women.
South Asian J Cancer. 2018 Apr-Jun;7(2):123-126. doi: 10.4103/sajc.sajc_117_18.
10
Practical consensus recommendations on management of HR + ve early breast cancer with specific reference to genomic profiling.
South Asian J Cancer. 2018 Apr-Jun;7(2):96-101. doi: 10.4103/sajc.sajc_110_18.
引用本文的文献
1
Aggressive Male Breast Cancer-Clinical and Therapeutic Aspects Correlated with the Histopathological Examination: A Case Report and Literature Review.
Medicina (Kaunas). 2023 Dec 14;59(12):2167. doi: 10.3390/medicina59122167.
2
A quality evaluation of the clinical practice guidelines on breast cancer using the RIGHT checklist.
Ann Transl Med. 2021 Jul;9(14):1174. doi: 10.21037/atm-21-2884.
3
Is Surgical Management of Primary Beneficial in Metastatic Breast Cancer??
Indian J Surg Oncol. 2021 Jun;12(2):421-427. doi: 10.1007/s13193-021-01329-1. Epub 2021 Apr 27.
4
Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience.
PLoS One. 2020 Aug 24;15(8):e0237811. doi: 10.1371/journal.pone.0237811. eCollection 2020.
本文引用的文献
1
Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial.
Lancet Oncol. 2015 Oct;16(13):1380-8. doi: 10.1016/S1470-2045(15)00135-7. Epub 2015 Sep 9.
2
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.
N Engl J Med. 2015 Feb 19;372(8):724-34. doi: 10.1056/NEJMoa1413513.
3
Primary metastatic breast cancer: the impact of locoregional therapy.
Breast Care (Basel). 2014 Feb;9(1):23-8. doi: 10.1159/000360054.
4
Challenges to effective cancer control in China, India, and Russia.
Lancet Oncol. 2014 Apr;15(5):489-538. doi: 10.1016/S1470-2045(14)70029-4.
5
Meta-analysis to determine if surgical resection of the primary tumour in the setting of stage IV breast cancer impacts on survival.
Ann Surg Oncol. 2013 Sep;20(9):2828-34. doi: 10.1245/s10434-013-2998-2. Epub 2013 May 8.
6
Can locoregional treatment of the primary tumor improve outcomes for women with stage IV breast cancer at diagnosis?
Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):39-45. doi: 10.1016/j.ijrobp.2011.11.046. Epub 2012 Feb 11.
7
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.
N Engl J Med. 2012 Jan 12;366(2):109-19. doi: 10.1056/NEJMoa1113216. Epub 2011 Dec 7.
8
Breast radiotherapy as part of loco-regional treatments in stage IV breast cancer patients with oligometastatic disease.
Radiother Oncol. 2010 Aug;96(2):199-203. doi: 10.1016/j.radonc.2010.02.028. Epub 2010 Mar 27.
9
Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis.
Eur J Surg Oncol. 2009 Nov;35(11):1146-51. doi: 10.1016/j.ejso.2009.03.012. Epub 2009 Apr 26.
10
Association of surgery with improved survival in stage IV breast cancer patients.
Ann Surg. 2008 May;247(5):732-8. doi: 10.1097/SLA.0b013e3181656d32.
Zotero 插件